These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9116321)

  • 21. C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells.
    Venditti M; Iwasiow B; Orr FW; Shiu RP
    Int J Cancer; 2002 May; 99(1):35-42. PubMed ID: 11948489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7.
    Wang TT; Phang JM
    Cancer Res; 1995 Jun; 55(12):2487-9. PubMed ID: 7780952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of BAX and BCL-2 expression in breast cancer cells by chemotherapy.
    Gibson LF; Fortney J; Magro G; Ericson SG; Lynch JP; Landreth KS
    Breast Cancer Res Treat; 1999 May; 55(2):107-17. PubMed ID: 10481938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells.
    Dubik D; Dembinski TC; Shiu RP
    Cancer Res; 1987 Dec; 47(24 Pt 1):6517-21. PubMed ID: 3677090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of estrogen, antiestrogen and UV-light on the balance between proliferation and apoptosis in MCF-7 breast adenocarcinoma cells culture.
    Swiatecka J; Dziecioł J; Anchim T; Dabrowska M; Pietruczuk M; Wołczyński S
    Neoplasma; 2000; 47(1):15-24. PubMed ID: 10870682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonism between estradiol and progestin on Bcl-2 expression in breast-cancer cells.
    Kandouz M; Siromachkova M; Jacob D; Chretien Marquet B; Therwath A; Gompel A
    Int J Cancer; 1996 Sep; 68(1):120-5. PubMed ID: 8895551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. pIXY321 protects against Ara-C or taxol-induced apoptosis and loss of clonogenic survival of normal human bone marrow progenitor cells.
    Bhalla K; Ibrado AM; Bradt JE; Ray S; Huang Y; Tang C; Nawabi A; Hoffman R
    Leukemia; 1995 Nov; 9(11):1851-6. PubMed ID: 7475274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pure antiestrogen ICI 182780 is more effective in the induction of apoptosis and down regulation of BCL-2 than tamoxifen in MCF-7 cells.
    Diel P; Smolnikar K; Michna H
    Breast Cancer Res Treat; 1999 Nov; 58(2):87-97. PubMed ID: 10674872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression.
    Raha P; Thomas S; Thurn KT; Park J; Munster PN
    Breast Cancer Res; 2015 Feb; 17(1):26. PubMed ID: 25848915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ; Jordan VC
    Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of apoptosis in mammary gland by a pure anti-estrogen ICI 182780.
    Lim KB; Ng CY; Ong CK; Ong CS; Tran E; Nguyen TT; Chan GM; Huynh H
    Breast Cancer Res Treat; 2001 Jul; 68(2):127-38. PubMed ID: 11688516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissociation of vitamin D3 and anti-estrogen mediated growth regulation in MCF-7 breast cancer cells.
    Nolan E; Donepudi M; VanWeelden K; Flanagan L; Welsh J
    Mol Cell Biochem; 1998 Nov; 188(1-2):13-20. PubMed ID: 9823006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells.
    Vendrell JA; Ghayad S; Ben-Larbi S; Dumontet C; Mechti N; Cohen PA
    Oncogene; 2007 Jul; 26(32):4656-67. PubMed ID: 17297453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling.
    Badia E; Duchesne MJ; Semlali A; Fuentes M; Giamarchi C; Richard-Foy H; Nicolas JC; Pons M
    Cancer Res; 2000 Aug; 60(15):4130-8. PubMed ID: 10945620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Taxol-induced ceramide generation and apoptosis in human breast cancer cells.
    Charles AG; Han TY; Liu YY; Hansen N; Giuliano AE; Cabot MC
    Cancer Chemother Pharmacol; 2001 May; 47(5):444-50. PubMed ID: 11391861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
    Revillion F; Pawlowski V; Lhotellier V; Louchez MM; Peyrat JP
    Anticancer Res; 2003; 23(2B):1455-60. PubMed ID: 12820409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential sensitivity of MCF-7 and LCC2 cells, to multiple growth inhibitory agents: possible relation to high bcl-2/bax ratio?
    Lilling G; Hacohen H; Nordenberg J; Livnat T; Rotter V; Sidi Y
    Cancer Lett; 2000 Dec; 161(1):27-34. PubMed ID: 11078910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of growth-factor-activated proliferation by anti-estrogens and effects on early gene expression of MCF-7 cells.
    Wosikowski K; Küng W; Hasmann M; Löser R; Eppenberger U
    Int J Cancer; 1993 Jan; 53(2):290-7. PubMed ID: 8425767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tamoxifen-induced apoptosis in breast cancer cells relates to down-regulation of bcl-2, but not bax and bcl-X(L), without alteration of p53 protein levels.
    Zhang GJ; Kimijima I; Onda M; Kanno M; Sato H; Watanabe T; Tsuchiya A; Abe R; Takenoshita S
    Clin Cancer Res; 1999 Oct; 5(10):2971-7. PubMed ID: 10537367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation.
    Kyprianou N; English HF; Davidson NE; Isaacs JT
    Cancer Res; 1991 Jan; 51(1):162-6. PubMed ID: 1899037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.